Development and validation of risk score for predicting positive repeat prostate biopsy in patients with a previous negative biopsy in a UK population

BMC Urology

Volumn 9, Issue 1, 2009, Pages

  Rochester, Mark A ^a   Pashayan, Nora ^c   Matthews, Fiona ^c   Doble, Andrew ^a   McLoughlin, John ^a,b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b WEST SUFFOLK HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CALCULATION; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RISK; CANCER STAGING; CLINICAL ARTICLE; DATA BASE; DIAGNOSTIC ACCURACY; DIGITAL RECTAL EXAMINATION; HISTOLOGY; HUMAN; MALE; MEDICAL DECISION MAKING; OUTPATIENT; POPULATION; PROSTATE BIOPSY; PROSTATE CANCER; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; TUMOR VOLUME; UNITED KINGDOM; UROLOGY; VALIDATION STUDY; AGED; BIOPSY; EVALUATION; INCIDENCE; LABORATORY DIAGNOSIS; METHODOLOGY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; PROSTATE TUMOR; REPRODUCIBILITY; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; UTILIZATION REVIEW;

AGED; BIOPSY; FALSE NEGATIVE REACTIONS; GREAT BRITAIN; HUMANS; INCIDENCE; MALE; PROPORTIONAL HAZARDS MODELS; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 68749096084     PISSN: 14712490     EISSN: 14712490     Source Type: Journal    
DOI: 10.1186/1471-2490-9-7     Document Type: Article

References (18)

1. UK Prostate Cancer incidence statistics. Cancer Research UK, http://info.cancerresearchuk.org/cancerstats/types/prostate/incidence/ Incidence UK
2. Biopsy standards for detection of prostate cancer. B Djavan M Margreiter, World J Urol 2007 25 1 11 7 10.1007/s00345-007-0151-1 17342490
3. Risks and complications of transrectal ultrasound guided prostate needle biopsy: a prospective study and review of the literature. LV Rodriguez MK Terris, J Urol 1998 160 6 Pt 1 2115 20 9817335
4. Diagnosis and treatment of prostate cancer: summary of NICE guidance. J Graham M Baker F Macbeth V Titshall, Bmj 2008 336 7644 610 2 18340076 10.1136/bmj.39498.525706.AD
5. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men. B Djavan A Zlotta M Remzi K Ghawidel A Basharkhah CC Schulman M Marberger, J Urol 2000 163 4 1144 8 discussion 1148-9. 10.1016/S0022-5347(05)67711-7 10737484
6. Predictors of subsequent prostate cancer in men with a prostate specific antigen of 2.6 to 4.0 ng/ml and an initially negative biopsy. SE Eggener KA Roehl WJ Catalona, J Urol 2005 174 2 500 4 10.1097/01.ju.0000165203.40973.0f 16006880 (Pubitemid 40981584)
7. Predictors of first repeat biopsy cancer detection with suspected local stage prostate cancer. JE Fowler Jr SA Bigler D Miles DA Yalkut, J Urol 2000 163 3 813 8 10.1016/S0022-5347(05)67810-X 10687983
8. Predictors of prostate cancer after initial negative systematic 12 core biopsy. H Singh EI Canto SF Shariat D Kadmon BJ Miles TM Wheeler KM Slawin, J Urol 2004 171 5 1850 4 10.1097/01.ju.0000119667.86071.e7 15076292 (Pubitemid 38501021)
9. Atypical foci suspicious but not diagnostic of malignancy in prostate needle biopsies (also referred to as "atypical small acinar proliferation suspicious for but not diagnostic of malignancy"). R Montironi V Scattoni R Mazzucchelli A Lopez-Beltran DG Bostwick F Montorsi, Eur Urol 2006 50 4 666 74 10.1016/j.eururo.2006.07.048 16930809 (Pubitemid 44349033)
10. Evidence for the usefulness of nomograms. MW Kattan PT Scardino, Nat Clin Pract Urol 2007 4 12 638 9 10.1038/ncpuro0968 17984994 (Pubitemid 350238065)
11. A nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session. E Lopez-Corona M Ohori PT Scardino VE Reuter M Gonen MW Kattan, J Urol 2003 170 4 Pt 1 1184 8 discussion 1188. 10.1097/01.ju.0000087451.64657.fa 14501721 (Pubitemid 37108108)
12. An algorithm combining age, total prostate-specific antigen (PSA), and percent free PSA to predict prostate cancer: results on 4298 cases. GD Carlson CB Calvanese AW Partin, Urology 1998 52 3 455 61 10.1016/S0090-4295(98)00205-2 9730460 (Pubitemid 28399914)
13. Novel artificial neural network for early detection of prostate cancer. B Djavan M Remzi A Zlotta C Seitz P Snow M Marberger, J Clin Oncol 2002 20 4 921 9 10.1200/JCO.20.4.921 11844812 (Pubitemid 34141833)
14. Validation of a nomogram for predicting positive repeat biopsy for prostate cancer. BV Yanke M Gonen PT Scardino MW Kattan, J Urol 2005 173 2 421 4 10.1097/01.ju.0000150522.82760.00 15643192
15. Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. DW Keetch WJ Catalona DS Smith, J Urol 1994 151 6 1571 4 7514690
16. Prognostic Significance of High-Grade Prostatic Intraepithelial Neoplasia (HGPIN): Risk of Prostatic Cancer on Repeat Biopsies. F Gallo L Chiono E Gastaldi E Venturino C Giberti, Urology 2008 72 3 628 32 10.1016/j.urology.2007. 11.115 18279918
17. The proportion of cores with high-grade prostatic intraepithelial neoplasia on extended-pattern needle biopsy is significantly associated with prostate cancer on site-directed repeat biopsy. A Akhavan JD Keith SI Bastacky C Cai Y Wang JB Nelson, BJU Int 2007 99 4 765 9 10.1111/j.1464-410X.2006.06681.x 17378840 (Pubitemid 46439563)
18. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer. L Schoenfield JS Jones CD Zippe AM Reuther E Klein M Zhou C Magi-Galluzzi, BJU Int 2007 99 4 770 4 10.1111/j.1464-410X.2006. 06728.x 17233800 (Pubitemid 46439582)